Action of modafinil through histaminergic and orexinergic neurons.

作者: Tomoko Ishizuka , Tomotaka Murotani , Atsushi Yamatodani

DOI: 10.1016/B978-0-12-394623-2.00014-7

关键词:

摘要: Modafinil is a wake-promoting drug used for the treatment of excessive daytime sleepiness due to narcolepsy as well associated with obstructive sleep apnea and shift work disorder. Although effect modafinil expressed through dopaminergic norepinephrinergic systems similar that classical psychostimulants, mechanism action distinct from those compounds in terms involvement histaminergic orexinergic systems. activates system an indirect manner, presumably via attenuation inhibitory GABAergic input neurons. The controls arousal system, modafinil-induced increment histamine release abolished orexin neuron-ablated mice, suggesting increases tone Clinical experimental investigations have suggested less importance modafinil, but considered be involved alertness or synaptic plasticity.

参考文章(85)
Paige Beck, Angela Odle, Tiffany Wallace-Huitt, Robert D. Skinner, Edgar Garcia-Rill, Modafinil increases arousal determined by P13 potential amplitude: an effect blocked by gap junction antagonists. Sleep. ,vol. 31, pp. 1647- 1654 ,(2008) , 10.1093/SLEEP/31.12.1647
Nishino S, Julie Mao, Raghavan Sampathkumaran, Jeff Shelton, None, Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants. Sleep research online : SRO. ,vol. 1, pp. 49- 61 ,(1998)
W.T. Longstreth, Thomas D. Koepsell, Thanh G. Ton, Audrey F. Hendrickson, Gerald van Belle, The epidemiology of narcolepsy. Sleep. ,vol. 30, pp. 13- 26 ,(2007) , 10.1093/SLEEP/30.1.13
E. Mignot, S. Nishino, C. Guilleminault, W. C. Dement, Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep. ,vol. 17, pp. 436- 437 ,(1994) , 10.1093/SLEEP/17.5.436
Takashi Kanbayashi, Tohru Kodama, Hideaki Kondo, Shinsuke Satoh, Yuichi Inoue, Shigeru Chiba, Tetsuo Shimizu, Seiji Nishino, CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome. Sleep. ,vol. 32, pp. 181- 187 ,(2009) , 10.1093/SLEEP/32.2.181
Christelle Peyron, Juliette Faraco, William Rogers, Beth Ripley, Sebastiaan Overeem, Yves Charnay, Sona Nevsimalova, Michael Aldrich, David Reynolds, Roger Albin, Robin Li, Marcel Hungs, Mario Pedrazzoli, Muralidhara Padigaru, Melanie Kucherlapati, Jun Fan, Richard Maki, Gert Jan Lammers, Constantin Bouras, Raju Kucherlapati, Seiji Nishino, Emmanuel Mignot, None, A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains Nature Medicine. ,vol. 6, pp. 991- 997 ,(2000) , 10.1038/79690
Seiji Nishino, Eiko Sakurai, Sona Nevsimalova, Yasushi Yoshida, Takehiko Watanabe, Kazuhik Yanai, Emmanuel Mignot, Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls Sleep. ,vol. 32, pp. 175- 180 ,(2009) , 10.1093/SLEEP/32.2.175
Jonathan P. Wisor, Seiji Nishino, Ichiro Sora, George H. Uhl, Emmanuel Mignot, Dale M. Edgar, Dopaminergic role in stimulant-induced wakefulness. The Journal of Neuroscience. ,vol. 21, pp. 1787- 1794 ,(2001) , 10.1523/JNEUROSCI.21-05-01787.2001
RX Guo, C Anaclet, JC Roberts, R Parmentier, M Zhang, G Guidon, C Buda, JP Sastre, JQ Feng, P Franco, SH Brown, N Upton, AD Medhurst, JS Lin, Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep–wake cycle and narcoleptic episodes in Ox−/− mice British Journal of Pharmacology. ,vol. 157, pp. 104- 117 ,(2009) , 10.1111/J.1476-5381.2009.00205.X
Thomas C. Thannickal, Robert Nienhuis, Jerome M. Siegel, Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy Sleep. ,vol. 32, pp. 993- 998 ,(2009) , 10.1093/SLEEP/32.8.993